A report on a modified protocol for flow cytometry‐based assessment of blood group erythrocyte antigens potentially suitable for analysis of weak ABO subgroups
Transfusion · 2023
DOI: 10.1111/trf.17239 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Transfusion, 2023. Verfasst von Makoto Otsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: ABO Blood-Group System, Erythrocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Flow cytometry (FC) has proven its utility in scrutinizing AB antigen expression in red blood cells (RBCs), cooperating with serological tests for accurate blood group typing. However, technical difficulties may impair the characterization of weak ABO subtypes when background noises appear at non‐negligible levels. Study design and methods We sought to establish an FC method that could prevent antibody‐induced hemagglutination and an increase in cellular autofluorescence, two major issues inherent to RBC‐FC analysis of AB expression. We optimized fixatives, multicolor‐staining protocols, and sequential gating strategies. Blood samples from weak ABO subtype cases, B m and A el , were analyzed with the established protocol.
Results
The optimized mixture of glutaraldehyde and formaldehyde successfully generated fixed RBCs resistant to agglutination while maintaining low autofluorescence. These features allowed co‐staining of leukocyte‐ and erythrocyte‐markers, which enabled sequential gating strategies facilitating the precise AB antigen analysis in purely single RBCs with minimum background noises. By the established FC analysis, we could detect in the B m sample a small RBC population exhibiting weak B antigen expression. The assay also proved it feasible to identify a small population (0.04%) of RBCs weakly expressing the A antigen in the A el sample confirmed as harboring a rare c.816dupG ABO variant allele.
Conclusion
The RBC‐FC analysis described here allows the detection of AB antigens weakly expressed in RBCs while achieving minimum background noise levels in negative control samples. Overall, the modified protocol provides a quick and reliable assay valuable in transfusion medicine and is potentially applicable to the characterization of rare weak ABO variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Clinical Laboratory, Kitasato University Hospital, Sagamihara, Japan.
ORCID-Profile: Makoto Otsu
Zitieren
APA
Otsu, M., Tanabe, Y., Iwakiri, A., Arima, K., Uchiyama, A., Yamamoto, M., Ohtani, S., Endo, H., Komoto, M., & Miyazaki, K. (2023). A report on a modified protocol for flow cytometry‐based assessment of blood group erythrocyte antigens potentially suitable for analysis of weak ABO subgroups. Transfusion. https://doi.org/10.1111/trf.17239
Vancouver
Otsu M, Tanabe Y, Iwakiri A, Arima K, Uchiyama A, Yamamoto M, et al. A report on a modified protocol for flow cytometry‐based assessment of blood group erythrocyte antigens potentially suitable for analysis of weak ABO subgroups. Transfusion. 2023. doi:10.1111/trf.17239
BibTeX
@article{Otsu2023,
author = {Otsu, Makoto and Tanabe, Yuji and Iwakiri, Ayako and Arima, Kazuna and Uchiyama, Anna and Yamamoto, Marina and Ohtani, Shinichi and Endo, Hiroshi and Komoto, Mina and Miyazaki, Koji},
title = {A report on a modified protocol for flow cytometry‐based assessment of blood group erythrocyte antigens potentially suitable for analysis of weak ABO subgroups},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17239}
}
EUVIMED